Search Results - Heudel, Thibaut

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors

    Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 in... by Blanchart, Katrien, Heudel, Thibaut, Ardouin, Pierre, Lemaitre, Adrien, Briet, Clément, Bignon, Mathieu, Sabatier, Rémi, Legallois, Damien, Roule, Vincent, Beygui, Farzin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

    Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion by Roule, Vincent, Heudel, Thibaut, Lemaitre, Adrien, Bignon, Mathieu, Ardouin, Pierre, Sabatier, Rémi, Blanchart, Katrien, Beygui, Farzin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

    Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion by Roule, Vincent, Heudel, Thibaut, Lemaitre, Adrien, Bignon, Mathieu, Ardouin, Pierre, Sabatier, Rémi, Blanchart, Katrien, Beygui, Farzin

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

    Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers by Labidi-Galy, S. Intidhar, de La Motte Rouge, Thibault, Derbel, Olfa, Wolfer, Anita, Kalbacher, Elsa, Olivier, Timothée, Combes, Jean-Damien, Heimgartner-Hu, Ketty, Tredan, Olivier, Guevara, Hemerson, Heudel, Pierre-Etienne, Reverdy, Thibaut, Bazan, Fernando, Heinzelmann-Schwarz, Viola, Fehr, Mathias, de Castelbajac, Victoire, Vaflard, Pauline, Crivelli, Louise, Bonadona, Valerie, Viassolo, Valeria, Buisson, Adrien, Golmard, Lisa, Rodrigues, Manuel, Ray-Coquard, Isabelle

    Published in Gynecologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study

    A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study by Hodroj, Khalil, Pellegrin, David, Menard, Cindy, Bachelot, Thomas, Durand, Thierry, Toussaint, Philippe, Dufresne, Armelle, Mery, Benoite, Tredan, Olivier, Goulvent, Thibaut, Heudel, Pierre

    Published in JMIR cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: